Overview
Areas of Research/Interest
- Optimizing biomarker directed treatment for late-stage lung cancer
- Optimizing treatment for patients with lung cancer and brain metastases
- Finding novel targets in early and advanced stage lung cancer
- Optimizing access to health care in women and minorities facing lung cancer
Current Appointments & Affiliations
Assistant Professor of Medicine
·
2023 - Present
Medicine, Medical Oncology,
Medicine
Member of the Duke Cancer Institute
·
2024 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
Neoadjuvant, Perioperative, and Adjuvant Immunotherapy in Early-Stage Surgically Resectable Non-Small Cell Lung Cancer: Updates and Future Perspectives.
Preprint · May 5, 2025 Full text CiteAcute Anemia
Journal Article · 2025 Anemia is characterized by a deficiency in the number of circulating red blood cells (RBCs), the amount of hemoglobin, or the volume of packed RBCs, known as hematocrit. The World Health Organization (WHO) defines anemia as a hemoglobin level below 13 g/dL ... CiteUnique genomic alterations in the circulating tumor DNA of patients with solid tumors brain metastases.
Journal Article Neurooncol Adv · 2024 BACKGROUND: Although serum circulating tumor DNA (ctDNA) is routine, data from patients with brain metastases (BrMs) is limited. We assessed genomic alterations in ctDNA from patients with solid tumor BrMs in 3 groups: Isolated BrMs with stable extracrania ... Full text Link to item CiteRecent Grants
An Open-Label, Phase 1/2 Study of ORIC-114 as a Single Agent or in Combination with Chemotherapy, in Patients with Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
Clinical TrialPrincipal Investigator · Awarded by ORIC Pharmaceuticals, Inc. · 2024 - 2029A randomized pilot study comparing the feasibility of using a virtual agent vs. an off-site human agent to onboard oncology patients to remote patient AI monitoring devices
Clinical TrialPrincipal Investigator · Awarded by NTT DATA Americas, Inc. · 2025 - 2029BGBC016 STK11 NSCLC
Clinical TrialPrincipal Investigator · Awarded by BerGenBio ASA · 2023 - 2028View All Grants
Education, Training & Certifications
University of Queensland (Australia) ·
2017
M.D.